Quality Bioresources
Private Company
Funding information not available
Overview
Quality BioResources is a specialized contract manufacturer providing critical lyophilization services to diverse life science and consumer industries. The company leverages a 30,000+ square foot facility in Texas, featuring industrial-scale lyophilizers and ISO 13485 certification for medical device manufacturing, positioning it as a key partner for sensitive biologics, diagnostics, and biomaterials. Its business model is purely service-based, generating revenue through contract manufacturing without developing its own therapeutic or diagnostic products. QBI's value proposition centers on scalability, quality assurance, and decades of formulation expertise for complex freeze-drying applications.
Technology Platform
Industrial-scale lyophilization (freeze-drying) and custom formulation services for stabilizing sensitive biologicals, diagnostics, and biomaterials. Includes cycle development, filling, and biomaterials processing.
Opportunities
Risk Factors
Competitive Landscape
QBI competes with other specialized lyophilization CDMOs and broader contract manufacturing organizations (CMOs). Its differentiation lies in its specific focus on diagnostics, biomaterials, and cosmetics, its claimed scalable capacity in the central US, and its ISO 13485 certification. It likely competes on flexibility, technical expertise in formulation, and cost for small-to-mid volume runs.